Rhus verniciflua Stokes extract suppresses migration and invasion in human gastric adenocarcinoma AGS cells
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Many studies have suggested that Rhus verniciflua Stokes (RVS) and its extract are anticancer agents. However, RVS had limited use because it contains urushiol, an allergenic toxin. By improving an existing allergen-removal extraction method, we developed a new allergen-free Rhus verniciflua Stokes extract (RVSE) with higher flavonoid content. In this study, we examined whether RVSE inhibits the ability of AGS gastric cancer cells to migrate and invade. MATERIALS/METHODS: The flavonoids content of RVSE was analyzed by HPLC. The effects of RVSE on migration and invasion in AGS cells were analyzed by each assay kit. Matrix metalloproteinase (MMP)-9, plasminogen activator inhibitor-1 (PAI-1) and urokinase-type plasminogen activator (uPA) protein expression was analyzed by protein antibody array. The Phosphorylation of signal transducer and activator of transcription (STAT) 3 were assayed by Western blot analysis. RESULTS: RVSE treatment with 0–100 μg/mL dose-dependently reduced the ability of AGS cells to migrate and invade. Notably, treatment with RVSE strongly inhibited the expression of MMP-9 and uPA and the phosphorylation of STAT3. In contrast, RVSE treatment dramatically increased the expression of PAI-1. These results indicate that the inhibition of MMP-9 and uPA expression and STAT3 phosphorylation and the stimulation of PAI-1 expression contributed to the decreased migration and invasion of AGS cells treated with RVSE. CONCLUSIONS: These results suggest that RVSE may be used as a natural herbal agent to reduce gastric cancer metastasis.
Abstract
BACKGROUND/OBJECTIVES: Many studies have suggested that Rhus verniciflua Stokes (RVS) and its extract are anticancer agents. However, RVS had limited use because it contains urushiol, an allergenic toxin. By improving an existing allergen-removal extraction method, we developed a new allergen-free Rhus verniciflua Stokes extract (RVSE) with higher flavonoid content. In this study, we examined whether RVSE inhibits the ability of AGS gastric cancer cells to migrate and invade. MATERIALS/METHODS: The flavonoids content of RVSE was analyzed by HPLC. The effects of RVSE on migration and invasion in AGS cells were analyzed by each assay kit. Matrix metalloproteinase (MMP)-9, plasminogen activator inhibitor-1 (PAI-1) and urokinase-type plasminogen activator (uPA) protein expression was analyzed by protein antibody array. The Phosphorylation of signal transducer and activator of transcription (STAT) 3 were assayed by Western blot analysis. RESULTS: RVSE treatment with 0–100 μg/mL dose-dependently reduced the ability of AGS cells to migrate and invade. Notably, treatment with RVSE strongly inhibited the expression of MMP-9 and uPA and the phosphorylation of STAT3. In contrast, RVSE treatment dramatically increased the expression of PAI-1. These results indicate that the inhibition of MMP-9 and uPA expression and STAT3 phosphorylation and the stimulation of PAI-1 expression contributed to the decreased migration and invasion of AGS cells treated with RVSE. CONCLUSIONS: These results suggest that RVSE may be used as a natural herbal agent to reduce gastric cancer metastasis.
참고문헌 (68)
- Forman D, "Gastric cancer : global pattern of the disease and an overview of environmental risk factors", Best Pract Res Clin Gastroenterol, 20, pp.633~649 (2006)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- Akagi T, "Lymph node metastasis of gastric cancer", Cancers(Basel), 3, pp.2141~2159 (2011)
- Werner M, "Gastric adenocarcinoma : pathomorphology and molecular pathology", J Cancer Res Clin Oncol, 127, pp.207~216 (2001)
- Fidler IJ, "The pathogenesis of cancer metastasis : the ‘seed and soil’ hypothesis revisited", Nat Rev Cancer, 3, pp.453~458 (2003)
- Chaffer CL, "A perspective on cancer cell metastasis", Science, 331, pp.1559~1564 (2011)
- Jang IS, "Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells", Oncol Rep, 36, pp.3037~3043 (2016)
- Lee KW, "Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells", Oncol Rep, 39, pp.1141~1147 (2018)
- 장하리, "Flavonol glycosides from the aerial parts of Gynostemma pentaphyllum and their antioxidant activity", Archives of Pharmacal Research, 39(9), pp.1232~1236 (2016), 대한약학회
- Jang HS, "Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells", Biochim Biophys Acta, 1726, pp.309~316 (2005)
- Jung CH, "Rhus verniciflua Stokes extract : radical scavenging activities and protective effects on H2O2-induced cytotoxicity in macrophage RAW 264. 7 cell lines", Biol Pharm Bull, 29, pp.1603~1607 (2006)
- Jung CH, "Phenolic-rich fraction from Rhus verniciflua Stokes(RVS)suppress inflammatory response via NF-κB and JNK pathway in lipopolysaccharide-induced RAW 264. 7 macrophages", J Ethnopharmacol, 110, pp.490~497 (2007)
- Kitts DD, "Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes(RVS)", J Toxicol Environ Health A, 64, pp.357~371 (2001)
- Lee JC, "Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties", Biochim Biophys Acta, 1570, pp.181~191 (2002)
- Lee JC, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", Food Chem Toxicol, 42, pp.1383~1388 (2004)
- Lee SH, "Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract", J Altern Complement Med, 16, pp.497~500 (2010)
- Lee SO, "Comparison of the main components and bioactivity of Rhus verniciflua Stokes extracts by different detoxification processing methods", BMC Complement Altern Med, 18, pp.242~ (2018)
- Lim KT, "Antioxidant activity of a Rhus verniciflua Stokes ethanol extract", Food Chem Toxicol, 39, pp.229~237 (2001)
- Choi W, "Rhus verniciflua Stokes against advanced cancer : a perspective from the Korean Integrative Cancer Center", J Biomed Biotechnol, 2012, pp.874276~ (2012)
- Kim JH, "Inhibition of the PI3K-Akt", PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines, 2008, pp.265, 197~205
- Lee JO, "Rhus verniciflua extract modulates survival of MCF-7 breast cancer cells through the modulation of AMPK-pathway", Biol Pharm Bull, 37, pp.794~801 (2014)
- Kim JH, "Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells", Int J Mol Med, 18, pp.201~208 (2006)
- Son YO, "Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines", Toxicol Lett, 155, pp.115~125 (2005)
- Kim EJ, "Trans-10, cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth", Am J Physiol Gastrointest Liver Physiol, 283, pp.G357~G367 (2002)
- Cho HJ, "Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line", Am J Physiol Gastrointest Liver Physiol, 284, pp.G996~G1005 (2003)
- Kang SH, "Allergen-removed Rhus verniciflua extract induces ovarian cancer cell death via JNK activation", Am J Chin Med, 44, pp.1719~1735 (2016)
- Jung MH, "Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway", Carcinogenesis, 30, pp.655~661 (2009)
- Kang KA, "Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway", Tumour Biol, 37, pp.9615~9624 (2016)
- Kook SH, "Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G", Apoptosis, 12, pp.1289~1298 (2007)
- 이정채, "Ethanol-eluted Extract of Rhus verniciflua Stokes Inhibits Cell Growth and Induces Apoptosis inHuman Lymphoma Cells", BMB reports, 36(4), pp.337~343 (2003), 한국생화학분자생물학회
- Chae J, "Potential Efficacy of Allergen Removed Rhus Verniciflua Stokes Extract to Maintain Progression-Free Survival of Patients With Advanced Hepatobiliary Cancer", Explore(NY), 14, pp.300~304 (2018)
- Kim KS, "A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua Stokes extract", Integr Cancer Ther, 9, pp.100~104 (2010)
- Lee SH, "Impact of standardized Rhus verniciflua Stokes extract as complementary therapy on metastatic colorectal cancer : a Korean single-center experience", Integr Cancer Ther, 8, pp.148~152 (2009)
- Lee SH, "Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua Stokes extract: a case study", Explore(NY), 5, pp.242~244 (2009)
- Lee SK, "Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma : report of two cases", Ann Oncol, 21, pp.1383~1385 (2010)
- 최한석, "Urushiol이 제거된 발효옻 추출물의 제조와 특성", 한국식품과학회지, 44(2), pp.173~178 (2012), 한국식품과학회[DOI]
- Kobayashi S, "Artificial urushi : design, synthesis, and enzymatic curing of new urushiol analogues", Chem Lett, 29, pp.1214~1215 (2000)
- 최한석, "Biological Detoxification of Lacquer Tree (Rhus verniciflua Stokes) Stem Bark by Mushroom Species", Food Science and Biotechnology, 16(6), pp.935~942 (2007), 한국식품과학회
- Kim JH, "Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes", Am J Chin Med, 37, pp.609~620 (2009)
- Kim JH, "Integrating traditional medicine into modern inflammatory diseases care : multitargeting by Rhus verniciflua Stokes", Mediators Inflamm, 2014, pp.154561~ (2014)
- Jang JY, "Comparison of antibacterial activity and phenolic constituents of bark, lignum, leaves and fruit of Rhus verniciflua", PLoS One, 13, pp.e0200257~ (2018)
- Khan N, "Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo", Antioxid Redox Signal, 16, pp.1195~1204 (2012)
- Samoszuk M, "The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts", BMC Complement Altern Med, 5, pp.5~ (2005)
- Yit CC, "Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation", Cancer Lett, 82, pp.65~72 (1994)
- 박병철, "Protective effects of fustin, a flavonoid from Rhus vernicifluaStokes, on 6-hydroxydopamine-induced neuronal cell death", Experimental and Molecular Medicine, 39(3), pp.316~326 (2007), 생화학분자생물학회
- Liu T, "Composition analysis and antioxidant activities of the Rhus typhina L. stem", J Pharm Anal, 9, pp.332~338 (2019)
- Grynkiewicz G, "New perspectives for fisetin", Front Chem, 7, pp.697~ (2019)
- Lee JD, "Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models", Int Immunopharmacol, 9, pp.268~276 (2009)
- Lall RK, "Dietary flavonoid fisetin for cancer prevention and treatment", Mol Nutr Food Res, 60, pp.1396~1405 (2016)
- Hostetler GL, "Flavones : food sources, bioavailability, metabolism, and bioactivity", Adv Nutr, 8, pp.423~435 (2017)
- Kashyap D, "Fisetin : a bioactive phytochemical with potential for cancer prevention and pharmacotherapy", Life Sci, 194, pp.75~87 (2018)
- Wang TY, "Bioactive flavonoids in medicinal plants : structure, activity and biological fate", Asian J Pharm Sci, 13, pp.12~23 (2018)
- Syed DN, "Inhibition of Akt", mTOR signaling by the dietary flavonoid fisetin, 2013, pp.13, 995~1001
- Gupta SC, "Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols", Arch Biochem Biophys, 559, pp.91~99 (2014)
- Salerno S, "Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs", Curr Med Chem, 17, pp.4270~4290 (2010)
- Freije JM, "Matrix metalloproteinases and tumor progression", Adv Exp Med Biol, 532, pp.91~107 (2003)
- Tang L, "The urokinase plasminogen activator system in breast cancer invasion and metastasis", Biomed Pharmacother, 67, pp.179~182 (2013)
- Andreasen PA, "The urokinase-type plasminogen activator system in cancer metastasis : a review", Int J Cancer, 72, pp.1~22 (1997)
- Yuan ZL, "Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells", Mol Cell Biol, 24, pp.9390~9400 (2004)
- Akira S, "Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway", Cell, 77, pp.63~71 (1994)
- Lim CP, "Structure, function, and regulation of STAT proteins", Mol Biosyst, 2, pp.536~550 (2006)
- Silva CM, "Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis", Oncogene, 23, pp.8017~8023 (2004)
- Tkach M, "p42", p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth, 2013, pp.20, 197~212
- Alvarez JV, "Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor", Cancer Res, 66, pp.3162~3168 (2006)
- Klampfer L, "Signal transducers and activators of transcription(STATs) : Novel targets of chemopreventive and chemotherapeutic drugs", Curr Cancer Drug Targets, 6, pp.107~121 (2006)
- Kusaba T, "Activation of STAT3 is a marker of poor prognosis in human colorectal cancer", Oncol Rep, 15, pp.1445~1451 (2006)
- Yin W, "Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions", Mol Cancer, 5, pp.15~ (2006)
- Vlahopoulos SA, "Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue : molecular mode", Cancer Biol Med, 14, pp.254~270 (2017)